Kathleen D. Danenberg

Author

Also Known As

K D Danenberg, K Danenberg, K. D. Danenberg, K. DANENBERG, K. Danenberg, K.D. Danenberg, KATHLEEN D. DANENBERG, KATHLEEN DANENBERG, Kathleen D Danenberg, Kathleen D. Danenberg

266

Publications

15.8K

Citations

H-Index

109

Concepts

All Affiliations

University of Southern California University of Cologne USC Norris Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center Southern California University for Professional Studies

About

Kathleen D. Danenberg is an author at University of Southern California specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	77	6.4K
2	Natural Sciences	10	10	550
3	Biochemistry	8	8	789
4	Engineering	7	7	442
5	Health Sciences	4	4	151

Kathleen D. Danenberg

142

Publications

13.8K

Citations

H-Index

Page 1

	Year	Citations
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Dennis Salonga, Kathleen D. Danenberg, Martin R. Johnson, PubMed PathologyThymidylate SynthaseCancer BiologyTumor BiologyOncology	2000	833
Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. P. G. Johnston, Heinz-Josef Lenz, Cynthia G. Leichman, PubMed PathologyThymidylate SynthaseGastric TumorsCancer BiologyTumor Biology	1995	678
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Reginald V. Lord, Jan Brabender, David R. Gandara, PubMed	2002	671
<i>ERCC1</i> and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy Yoshinori Shirota, Jan Stoehlmacher, Jan Brabender, Journal of Clinical Oncology	2001	607
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. R. Metzger, Cynthia G. Leichman, Kathleen D. Danenberg, Journal of Clinical Oncology	1998	510
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. Cynthia G. Leichman, Heinz-Josef Lenz, Lawrence Leichman, Journal of Clinical Oncology	1997	479
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Jan Brabender, Kathleen D. Danenberg, Ralf Metzger, PubMed Tumor BiologyHer2-neu Mrna ExpressionHigh Her2-neu ExpressionMedicineCancer Cell Biology	2001	457
Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer Manuel Cobo, Dolores Isla, Bartomeu Massutí, Journal of Clinical Oncology	2007	442
An <i>In vivo</i> Platform for Translational Drug Development in Pancreatic Cancer Belén Rubio‐Viqueira, Antonio Jimeno, George Cusatis, Clinical Cancer Research	2006	411
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cindy A. Eads, Reginald V. Lord, Soudamini K. Kurumboor, PubMed Systems BiologyCpg Island HypermethylationEsophagusEsophageal CancerMedicine	2000	368

Page 1